Testing a new allergy shot for Japanese cedar pollen
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new allergy shot (ITI-9001) for people with Japanese cedar pollen allergy. It aims to see if the shot is safe and can reduce allergy symptoms. The study is for people who have not tried immunotherapy before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old and either male or a woman who cannot become pregnant.
- You have a confirmed allergy to Japanese cedar pollen (positive skin test and blood test).
- You have had seasonal eye/nose symptoms from Japanese cedar pollen for at least 2 years, needing medication.
- You do not have asthma that requires daily medicine (except mild or exercise-induced asthma).
- You have not had immunotherapy for Japanese cedar pollen before.
- You are willing to use effective contraception if you are a man with a partner who could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
This study tests a new injection called JYB1904 for people with year-round nasal allergies. It may help reduce symptoms like sneezing, stuffy nose, and runny nose.
This trial tests a new antibody treatment for eye allergy symptoms caused by birch pollen. It may help if you have severe eye allergies during birch season.
This Phase 3 trial tests whether an allergy treatment can reduce symptoms caused by grass and olive pollen. It also checks safety, especially for breathing and allergic reactions, in people with confirmed grass/olive allergy.
Hear when a new Allergen Immunotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.